xFOREST Therapeutics is a Kyoto-based young biotech company. At xFOREST, we develop a proprietary screening pipeline to find RNA-targeting small molecules with the goal to develop them into new drugs that treat previously untreatable diseases. Our pipeline includes both a highly automated laboratory system of liquid- and labware-handling devices and an automated analysis pipeline capable of statistically analyzing millions of potential RNA-small molecule interactions flagging promising hit-pairs. Our vision is to become a next-generation discovery platform that utilizes synergies between wet and dry lab, based on big data and AI.
Company Details
- Employees
- 21
- Founded
- 2020
- Address
- 46-29 Yoshida-Shimo Adachi-Cho, Kyoto,606-8304,japan
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- xforestx.com
- Keywords
- 港区.
- HQ
- Kyoto
Xforest Therapeutics Questions
Xforest Therapeutics's website is xforestx.com
Xforest Therapeutics's LinkedIn profile is https://jp.linkedin.com/company/xforest-therapeutics
Xforest Therapeutics has
21 employees.
View email and phone details for 21
employees at Xforest Therapeutics.
Xforest Therapeutics's industry is
Pharmaceutical Manufacturing
Xforest Therapeutics's top competitors are
Megakaryon Corporation,
Phost'in Therapeutics,
Agrodesign Studios,
Toleris Biotherapeutics Gmbh,
Alithea Bio,
Therna Therapeutics,
Cue Biopharma,
Rna Therapeutics Inc,
Reborna Biosciences, Inc.,
株式会社チェンジ.
Xforest Therapeutics's categories are Pharmaceutical Manufacturing
Xforest Therapeutics's founding year is 2020
